| ICBMX | PRNEX | ICBMX / PRNEX | |
| Total Expense Ratio | 1.31 | 0.77 | 170% |
| Annual Report Gross Expense Ratio | 1.31 | 0.77 | 170% |
| Fund Existence | 29 years | 57 years | - |
| Gain YTD | 14.144 | 17.573 | 80% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 121M | 2.51B | 5% |
| Annual Yield % from dividends | 0.66 | 1.81 | 36% |
| Returns for 1 year | 1.89 | 7.19 | 26% |
| Returns for 3 years | 9.24 | 7.57 | 122% |
| Returns for 5 years | 56.04 | 59.63 | 94% |
| Returns for 10 years | 70.47 | 74.71 | 94% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HFSFX | 17.10 | 0.13 | +0.77% |
| Hartford Schroders Intl Cntrrn Val F | |||
| RTNSX | 14.53 | 0.08 | +0.55% |
| Russell Inv Tax-Managed Intl Eq S | |||
| CMRAX | 10.73 | 0.01 | +0.09% |
| Calamos Merger Arbitrage A | |||
| ITGSX | 82.20 | N/A | N/A |
| VY® T. Rowe Price Growth Equity S | |||
| BRWBX | 27.80 | -0.04 | -0.14% |
| MFS Blended Research Growth Eq B | |||